Ontology highlight
ABSTRACT: Background
The 18F-fluoroestradiol positron emission tomography/computed tomography (18F-FES PET/CT) technique provides a convenient method to evaluate the overall estrogen receptor (ER) expression in metastatic breast cancer (MBC) patients. There are long debates on the characteristics and treatment strategy of patients with positive primary ER lesions but negative ER expression in metastatic disease. 18F-FES PET offers an opportunity to answer this question.Objectives
This study aimed to characterize the primary ER-positive patients with advanced-stage FES negativity and investigate the real-world treatment decisions made by physicians subsequently, and compare the efficacy between different regimens.Design
This observational cohort study was conducted at Fudan Un
SUBMITTER: You S
PROVIDER: S-EPMC10725097 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature